• <tr id='Vi4mEB'><strong id='Vi4mEB'></strong><small id='Vi4mEB'></small><button id='Vi4mEB'></button><li id='Vi4mEB'><noscript id='Vi4mEB'><big id='Vi4mEB'></big><dt id='Vi4mEB'></dt></noscript></li></tr><ol id='Vi4mEB'><option id='Vi4mEB'><table id='Vi4mEB'><blockquote id='Vi4mEB'><tbody id='Vi4mEB'></tbody></blockquote></table></option></ol><u id='Vi4mEB'></u><kbd id='Vi4mEB'><kbd id='Vi4mEB'></kbd></kbd>

    <code id='Vi4mEB'><strong id='Vi4mEB'></strong></code>

    <fieldset id='Vi4mEB'></fieldset>
          <span id='Vi4mEB'></span>

              <ins id='Vi4mEB'></ins>
              <acronym id='Vi4mEB'><em id='Vi4mEB'></em><td id='Vi4mEB'><div id='Vi4mEB'></div></td></acronym><address id='Vi4mEB'><big id='Vi4mEB'><big id='Vi4mEB'></big><legend id='Vi4mEB'></legend></big></address>

              <i id='Vi4mEB'><div id='Vi4mEB'><ins id='Vi4mEB'></ins></div></i>
              <i id='Vi4mEB'></i>
            1. <dl id='Vi4mEB'></dl>
              1. <blockquote id='Vi4mEB'><q id='Vi4mEB'><noscript id='Vi4mEB'></noscript><dt id='Vi4mEB'></dt></q></blockquote><noframes id='Vi4mEB'><i id='Vi4mEB'></i>
                Liver disease

                Home>Company>Corporate Events

                Convened the Zhejiang product conference successfully;

                Chitinase 3-like protein 1(Fibro-CHI) appeared on The 27th Conference of Asian Pacific Association for the Study of the liver(India).


                We acquired the price of official approval for the test items of Fibro-CHI by four provinces,including Hubei, Hunan,Tianjing and Zhejiang;

                Fibro-CHI made a splashy appearance at the Conference of American for the study of the liver,on October 20th,2017;

                Successfully took the lead in applying for the National Science and Technology Major Project and the Infectious Disease Prevention project;

                Won a “Winning enterprise award”from the 6th China Innovation and entrepreneurship Compition;

                Prof. Biaoyang Lin was offered as a visiting professor of the Third Affiliated Hospital of Sun Yat-sen University.


                Established the Zhejiang Proprium Health and Precision Medicine Research Institute;

                Signed a cooperation agreement with Pakistani Armed Forces Institute of Pathology;

                Proprium acquires a new Chinese invention patent.


                Acquired the ISO 13485 Quality System Management Certification;

                Proprium acquired CE certification for the products of the Heart Disease POCT Series, the detection of Fibro-CHI in liver fibrosis and the diagnosis of the liver cancer;

                Proprium acquires a new Chinese invention patent.


                Obtained the product registration certificate of zhejiang food and drug administration for the products of the detection of Fibro-CHI in liver fibrosis and the diagnosis of the liver cancer;


                Proprium acquires a new Chinese invention patent and two Japanese invention patents.


                Proprium was recognized as a Hangzhou new high-tech enterprise;

                Obtained the registered trademark for “Proprium Biotech”;

                Won the provincial science and technology program for the Liver cancer dual-label detection kit;


                Proprium Biotech moved to Yinhai Street, Xiasha, Hangzhou and completed the construction of GMP workshop;

                Proprium Biotech obtains the Permits for Medical Device Production Enterprises.


                Proprium Biotech Company was established in the Virgin Islands;

                Proprium Biotech(foreign-owned) was established with a registered capital of 10 million dollars,in Hangzhou Xiasha Singapore Science and Technology Park.